Current Roles

Employees:
33
Revenue:
$5.1M
About
FoRx Therapeutics is a recently incorporated privately-held company based in Basel, Switzerland. It is backed by a syndicate of investors that include the Novartis Venture Fund, Pfizer Ventures, M Ventures, Omega Funds and LSP Venture Capital. FoRx Therapeutics focuses on drugging key molecular targets involved in the DNA Replication Stress, as a new approach in the development of targeted anticancer drugs.
FoRx Therapeutics Address

Basel, null
FoRx Therapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.